BioCentury
ARTICLE | Company News

AltaRex Corp., Dompe International S.A. sales and marketing update

July 12, 2004 7:00 AM UTC

Dompe became the distributor in southern and eastern Europe for ALXFF's OvaRex oregovomab. The murine monoclonal antibody against CA125 is in Phase III testing to treat ovarian cancer. ...